IL1B and metabolic dysfunction-associated steatotic liver disease: Consistent with previous studies (Wu et al. 2019; McCall et al. 2023), our findings indicated aberrant expression of the pro‐inflammatory cytokines IL‐1β, IL‐6, and TNF‐α, as well as decreased expression of the anti‐inflammatory cytokine IL‐10 in NAFLD mice.